APSR2026-375

Yes
Regular
Submitted
Poster Presentation
 
AP07-001
P51
 
Format: PPTX Only
 
Format: PDF Only
03. Clinical Allergy and Immunology
9

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Shin Ohta * Juntendo University Faculty of Medicine and Graduate School of Medicine Department of Respiratory Medicine Tokyo Japan
Yoshihiko Sato - Juntendo University Faculty of Medicine and Graduate School of Medicine Department of Respiratory Medicine Tokyo Japan
Sonoko Harada - Juntendo University Faculty of Medicine and Graduate School of Medicine Department of Respiratory Medicine Tokyo Japan
Koichi Jingo - Juntendo University Faculty of Medicine and Graduate School of Medicine Department of Respiratory Medicine Tokyo Japan
Takayasu Nishimaki - Juntendo University Faculty of Medicine and Graduate School of Medicine Department of Respiratory Medicine Tokyo Japan
Sumiko Abe - Juntendo University Faculty of Medicine and Graduate School of Medicine Department of Respiratory Medicine Tokyo Japan
Shoko Ueda Matsuda - Juntendo University Faculty of Medicine and Graduate School of Medicine Department of Respiratory Medicine Tokyo Japan
Kazuhisa Takahashi - Juntendo University Faculty of Medicine and Graduate School of Medicine Department of Respiratory Medicine Tokyo Japan
Norihiko Harada - Juntendo University Faculty of Medicine and Graduate School of Medicine Department of Respiratory Medicine Tokyo Japan
-
-
-
-
-
-
Presenting Author Details
Shin
Ohta
s.ota.vl@juntendo.ac.jp
+819063492201
41-50
Japan
Original Research
Administration of a miR-146a mimic prevents steroid-resistant asthma in a mouse model
Maximum 25 words
Abstract Content
<p>In inflammatory processes, miR-146a is a key negative regulator that attenuates NF-κB signaling. While aberrant NF-κB activation is linked to steroid resistance in asthma, the contribution of miR-146a to this phenomenon remains poorly understood. This study aimed to investigate the role of miR-146a in the pathophysiology of steroid-resistant asthma by establishing an ovalbumin (OVA)-induced asthma model using miR-146a knockout (KO) and wild-type (WT) mice. Additionally, we examined the effect of administering a miR-146a mimic in OVA/chitin-induced steroid-resistant asthma model.</p>
<p>Female C57BL/6J WT and miR-146a KO mice were sensitized intraperitoneally with OVA on days 0 and 7, followed by intranasal challenges with OVA on days 20, 21, and 22 to establish an asthma model. During the challenge phase, dexamethasone (DEX) and/or the NF-κB inhibitor BAY 11-7085 were administered intraperitoneally. On day 23, bronchoalveolar lavage fluid (BALF) was collected to determine total and differential cell counts. To establish a steroid-resistant asthma model, intranasal chitin stimulation was co-administered during the OVA challenges on days 20, 21, and 22, and miR-146a mimics were administered on days 19, 20, and 21.</p>
<p>OVA challenge significantly increased the number and percentage of eosinophils in the BALF of both WT and miR-146a KO mice. While DEX administration significantly reduced eosinophil counts in WT mice, this suppressive effect was diminished in miR-146a KO mice. Notably, treatment with BAY 11-7085 in miR-146a KO mice restored DEX-induced eosinophil suppression to levels comparable to those of WT controls. In the OVA/chitin-induced steroid-resistant asthma model, co-administration with DEX and miR-146a mimics significantly inhibited eosinophilic airway inflammation, whereas DEX alone was ineffective.</p>
<p>These findings indicate that miR-146a deficiency induces steroid resistance, which can be mitigated by inhibiting NF-κB activation. Furthermore, miR-146a supplementation represents a potential novel therapeutic strategy for the treatment of steroid-resistant asthma.</p>
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
asthma, steroid-resistant, miR-146a
maximum 3 keywords and no abbreviations, separated by commas
 
299